Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxyurea to Prevent Central Nervous System (CNS) Complications of Sickle Cell Disease in Children

NCT01389024 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01389024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01389024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxyurea to Prevent Central Nervous System (CNS) Complications of Sickle Cell Disease in Children
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
August 16, 2012
Completion date
May 24, 2022
Enrollment
28 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, stroke